Clinical Trials Logo
  1. Home
  2. Normal Tension Glaucoma
  3. NCT00706056

A New View of Normal Tension Glaucoma: Autoregulation and Systemic Blood Pressure

Normal Tension Glaucoma Clinical Trial

Official title:
A New View of Normal Tension Glaucoma: Autoregulation and Systemic Blood Pressure

Clinical Trial Summary

The objective of this study is to determine whether systemic blood pressure in the body is related to the development and progression of normal tension glaucoma in the eye. The study aims to clarify whether subjects with episodes of hypotension (low blood pressure) at night are at increased risk for sight loss and the development of normal tension glaucoma.

Clinical Trial Description

Glaucoma is an eye disease that leads to damage of the optic nerve, visual field loss and can progress to blindness. Traditionally, glaucoma and its treatment have been closely linked to intraocular pressures. In normal tension glaucoma, damage to the optic nerve occurs without any increase in intraocular pressure. Normal tension glaucoma most often occurs in the elderly and can lead to loss of sight and significant disability. Subjects with progressive visual field loss are often a highly motivated group of subjects, ready to take an active part in the treatment of their condition. Investigating the risk factors that contribute to the development of normal-tension glaucoma may shed light on the progression of the disease.

Subjects with normal tension glaucoma will have their demographic and clinical characteristics recorded and their eyes examined at baseline, 6-months and 12 months. Subjects will wear an external blood pressure cuff for 48 hours that will record blood pressure every 30 minutes. This same blood pressure recording procedure will be performed at baseline, at 6 months, and at 12 months. At these same time intervals, visual fields will also be measured, as per routine clinical care, by the treating ophthalmologist. The results of the visual field testing will be recorded. The primary outcome of the study will be visual field abnormalities and their relationship to dips in systemic blood pressure. Results will be published and will be used as a base for future projects that may impact treatment and the understanding of risk factors of normal tension glaucoma. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT00706056
Study type Observational
Source Weill Medical College of Cornell University
Contact
Status Completed
Phase N/A
Start date September 2008
Completion date September 2011
View Details
See also
  Status Clinical Trial Phase
Completed NCT01995136 - Investigation of Intraocular Pressure (IOP) Reduction Efficacy of Travoprost Ophthalmic Solution in Patients With Normal Tension Glaucoma Phase 4
Not yet recruiting NCT05075369 - Water Drinking Test Study and Disc Hemorrhages in Normal Tension Glaucoma N/A
Completed NCT01769521 - Relationship Between 24-hour IOP Pattern and the 24-hour Blood Pressure Pattern in Patients With POAG N/A
Recruiting NCT01446497 - Efficacy and Safety Study of Combigan and 0.5% Timoptic in Normal Tension Glaucoma Phase 4
Terminated NCT01864317 - Assessment of Optic Nerve Radiation in Patients With Glaucoma and Ocular Hypertension by 7 Tesla Diffusion Tensor Imaging Phase 2
Not yet recruiting NCT00739154 - Protective Effect of Phenytoin on Glaucoma N/A
Recruiting NCT03761992 - Measurement of the Effect of Gingko Biloba Extract on Ocular and Nailfold Blood-flow in NTG N/A
Recruiting NCT05371977 - Deep Sclerectomy Versus Trabeculectomy in Normal Tension Glaucoma N/A
Completed NCT03106532 - Evaluation of PHP-201 Ophthalmic Solution in Patients With Normal Tension Glaucoma Phase 2
Completed NCT01175902 - Intraocular Pressure and Ocular Perfusion Pressure of Cosopt in Normal Tension Glaucoma N/A
Completed NCT01488032 - Differences in Nerve Fiber Layer Between Patients With Normal- and High-Pressure-Glaucoma N/A
Completed NCT00570362 - Systemic Glutathione Level in Normal Tension Glaucoma N/A
Recruiting NCT06449352 - Effect of Netarsudil vs Brimonidine in NTG Patients on Latanoprost Phase 4
Not yet recruiting NCT06023927 - Obstructive Sleep Apnea as a Risk Factor for Normal Tension Glaucoma and a Crucial Step in Preventing Blindness
Completed NCT04475900 - Computer-aided Diagnosis of Ocular Diseases Based on Corneal Biomechanics
Completed NCT02863705 - Efficacy and Safety of COMBIGAN® in Korean Patients With Primary Open Angle Glaucoma (POAG) and Normal Tension Glaucoma (NTG) Phase 4
Completed NCT00175786 - Magnetic Resonance Imaging of Patients With Normal Tension Glaucoma N/A
Completed NCT03323164 - Peripapillary Blood Flow After Use of Anti-glaucoma Medications: An OCT Angiography Study Phase 4
Completed NCT04014933 - Reproducibility of Blood Flowmetry in Human Retina Using the Nidek Laser Speckle Flowgraphy LSFG-NAVI System
Recruiting NCT01794442 - Study on the Oxygen Saturation in Pulsating and Non-pulsating Central Retinal Veins N/A